BIO-RAD LABORATORIES, INC. BIO Income Statement

Bio-rad laboratories, inc. (BIO)

Income statement / Yearly

Dec'19	Dec'18	Dec'17	Dec'16	Dec'15	Dec'14	Dec'13	Dec'12	Dec'11	Dec'10	Dec'09	Dec'08
Net sales
2,311	2,289	2,160	2,068	2,019	2,175	2,132	2,069	2,073	1,927	1,784	1,764
Cost of goods sold
1,054	1,066	972	929	897	996	954	914	894	835	784	801
Gross profit
1,256	1,223	1,187	1,138	1,121	1,178	1,178	1,155	1,178	1,091	999	962
Selling, general and administrative expense
824	834	806	814	761	808	798	681	695	635	601	591
Research and Development Expense
202	199	250	205	192	220	210	209	177	172	163	159
Impairment losses on goodwill and long-lived assets
0	292	11	62	0	0	-	-	-	-	3	28
Segment profit (loss)
229	-103	119	55	166	149	169	264	305	284	230	182
Interest expense
23	23	23	23	21	22	61	51	53	63	47	32
Foreign exchange (gains) losses, net
-2	-2	-9	-4	-10	-9	-8	-5	-13	-3	-5	7
Marketable Securities, Unrealized Gain (Loss)
2,030	606	0	0	-	-	-	-	-	-	-	-
Nonoperating Income (Expense)
26	36	10	13	11	13	12	21	7	3	6	0
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest
2,261	512	97	41	145	131	112	229	245	220	185	142
(Provision) benefit for income taxes
502	147	-24	15	36	42	34	64	67	33	36	44
Net income including noncontrolling interests
-	-	-	-	-	-	77	165	178	186	149	98
Net loss (income) attributable to noncontrolling interests
-	-	-	-	-	-	0	0	-0	1	4	8
Net Income (Loss) Attributable to Parent
1,758	365	122	26	109	88	77	165	179	185	144	89
Basic earnings per share:
Net income per share basic attributable to Bio-Rad
58.93	12.25	4.12	0.88	3.74	3.08	2.72	5.85	6.39	6.70	5.28	3.30
Weighted Average Number of Shares Outstanding, Basic
29	29	29	29	29	28	28	28	28	27	27	27
Diluted earnings per share:
Net income per share diluted attributable to Bio-Rad
58.27	12.10	4.07	0.88	3.71	3.05	2.69	5.78	6.29	6.59	5.20	3.24
Weighted Average Number of Shares Outstanding, Diluted
30	30	30	29	29	29	28	28	28	28	27	27